Artificial Intelligence
Smart Wearable Medical Devices Market Is Expected To Reach USD 37.4 Billion by 2030, Grow at a CAGR Of 13.1% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
<!– Name:DistributionId Value:8789429 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5500 –> <!– Name:CustomerId Value:1267475 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:80b34f45-7bc1-4431-b579-8113ee4bb041 –>
Farmington, March 17, 2023 (GLOBE NEWSWIRE) — The Global Smart Wearable Medical Devices Market size was valued at USD 13.8 Billion in 2021 and is projected to reach USD 37.4 Billion by 2030, growing at a CAGR of 13.1% from 2022 to 2030. Smart wearable devices will soon become more popular because they have a lot of features, can be used for telemedicine, and can be used all over the house. Wearable medical devices are in high demand because so many people have long-term illnesses like diabetes and heart problems. Continuous monitoring devices are used more and more as the number of people with these diseases goes up. In recent years, product sales have also gone up because of changes in technology that make people more mobile and connected. This has given the healthcare industry new ways to deal with patients and diseases. Smart wearable technologies will grow the market because they can improve the quality of patient care while cutting costs.
During the pandemic, the market for smart medical devices that you can wear has helped in some ways. As more innovative technologies are used to meet customer needs, the industry is expected to grow at a rate that has never been seen before. Smart wearable technology has made it easier for both patients and health care workers to keep track of their health from far away. As COVID-19 goes on, people are becoming more interested in health care, which is driving up the demand for daily health tracking devices that can be used at home. Also, at a time when patients can’t move around much and the risk of getting an infection in the facility is high, these devices have given chronically ill patients a good way to be monitored in real time.
Request Sample Copy of Report “Smart Wearable Medical Devices Market Size, Share & Trends Estimation Report By Type (Blood Pressure Monitor, Heart Detector, Blood Glucose Meter, Pulse Monitor, Others), By Application (Children, Adults, The Old, Other), By Region, And Segment Forecasts, 2023 – 2030”, published by Contrive Datum Insights.
Industry Developments:
- In March 2022, multinational pharmaceutical company Novo Nordisk announced that two connected insulin pens, NovoPen 6 and NovoPen Echo Plus, are now available by prescription in the UK for diabetics treated with Novo Nordisk insulin.
- In January 2022, Insulet, an innovative medical device company dedicated to simplifying the lives of people with diabetes, announced that its Omnipod 5 insulin pump has received FDA clearance for use in people with diabetes. The Omnipod 5 is a patch-like device that adjusts the daily dose based on changes in the wearer’s blood sugar levels.
Market Dynamics:
Drivers:
Demand is growing for monitoring patients from a distance. Wearable smart medical devices can make it possible to keep an eye on a patient from afar. This lets doctors and nurses check on the health of their patients outside of the typical clinic setting.
More and more people are getting chronic diseases. Diabetes and heart disease, for example, are on the rise. This is making people want smart medical devices that can be worn and help with these conditions.
Changes in technology: The market for smart wearable medical devices is likely to be driven by new technologies like artificial intelligence and machine learning, which will lead to new applications and use cases.
Favorable government initiatives: Governments all over the world are starting programmes to encourage the use of digital health technologies, which is expected to drive the growth of the smart wearable medical devices market.
Restraints:
Smart wearable medical devices can be expensive, which could make them less popular, especially in developing countries.
Limited reimbursement policies: It can be hard for patients to get wearable medical devices because reimbursement policies are limited. This can slow the spread of these technologies.
Concerns about data privacy: The use of smart wearable medical devices raises questions about data privacy and security, which could slow down their use.
Challenges:
Interoperability problems: It can be hard to get different smart wearable medical devices and health care systems to talk to each other.
Regulatory problems: The regulatory environment for smart wearable medical devices is complicated and changes quickly, which can cause problems for manufacturers and healthcare providers.
Battery life: Many smart wearable medical devices have short battery lives, which can be a problem, especially for devices that need to be worn all the time.
Regional Outlook:
The market for smart wearable medical devices in North America is expected to reach $8.92 billion by 2030, growing at a compound annual growth rate (CAGR) of 18.7% during the period of the forecast.
People with chronic diseases, good government programmes, and a well-developed healthcare system are some of the reasons why this region is expected to be a leading market.
The Europe region is also expected to grow a lot, thanks to things like the growing number of older people and the growing demand for remote patient monitoring.
Due to a large population, a rise in the number of people with chronic diseases, and higher healthcare costs, the Asia-Pacific region is expected to be a fast-growing market.
The Middle East and Africa are expected to grow slowly because more people are using digital health technologies and more attention is being paid to preventive care.
Latin America is also expected to have slow growth, which will be caused by things like rising healthcare costs and more people getting chronic diseases.
Buy this Premium Research Report@
https://www.contrivedatuminsights.com/buy/95407
Scope of Report:
| Report Attributes | Details |
| Growth Rate | CAGR of 13.1% from 2023 to 2030. |
| Revenue Forecast by 2030 | USD 37.4 Billion |
| By Type | Blood Pressure Monitor, Heart Detector, Blood Glucose Meter, Pulse Monitor, Others |
| By Application | Children, Adults, The Old, Other |
| By Companies | Google, IHealth Labs, Telefonica, Samsung Electronics, Cyberdyne, Sprint, IRhythm Technologies, Vendors to Watch Out, T-Mobile US, Interaxon, Emerging Vendors, Epson America, Lark, Orpyx Medical Technologies, Biosensics, Withings, Proteus Digital Health, Evena Medical, Cambridge Temperature Concepts, Sotera Wireless, Qardio |
| Regions and Countries Covered |
|
| Base Year | 2022 |
| Historical Year | 2017 to 2022 |
| Forecast Year | 2023 to 2030 |
Key Segments Covered:
Top Market Players:
Google, IHealth Labs, Telefonica, Samsung Electronics, Cyberdyne, Sprint, IRhythm Technologies, Vendors to Watch Out, T-Mobile US, Interaxon, Emerging Vendors, Epson America, Lark, Orpyx Medical Technologies, Biosensics, Withings, Proteus Digital Health, Evena Medical, Cambridge Temperature Concepts, Sotera Wireless, Qardio, and others.
By Type
- Blood Pressure Monitor
- Heart Detector
- Blood Glucose Meter
- Pulse Monitor
- Others
By Application
- Children
- Adults
- The Old
- Others
Regions and Countries Covered
- North America: (US, Canada, Mexico, Rest of North America)
- Europe: (Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
- Asia-Pacific: (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
- The Middle East & Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
- Latin America: (Brazil, Argentina, Rest of Latin America)
- Rest Of the World
Check out more related studies published by Contrive Datum Insights:
- Medical Supply Delivery Service Market – The global Medical Supply Delivery Service Market size was USD 50.33 Billion in 2022 and is expected to reach USD 97.5 Billion by 2030, with a CAGR of 7.6% from 2022 to 2030.
- Medical Devices Market – The Global Medical Devices Market Size Was Valued At USD 488.98 Billion In 2021. The Market Is Projected To Grow From USD 495.46 Billion In 2022 To USD 718.92 Billion By 2030, Exhibiting A CAGR Of 5.5% During The Forecast Period.
- Contact Lenses Market – The Global Contact Lenses Market Size Was Valued At USD 9.48 Billion In 2021. The Market Is Projected To Grow From USD 9.94 Billion In 2022 To USD 14.80 Billion By 2030, Exhibiting A CAGR Of 5.9% During The Forecast Period.
Customization of the Report: The report can be customized as per client needs or requirements.For any queries, you can contact us on [email protected] or +1 215-297-4078. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials at various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.
Social: Facebook / LinkedIn / Twitter
Contact Us:
Anna B. | Head Of Sales
Contrive Datum Insights
Phone: +91 9834816757 | +1 2152974078
Email: [email protected]
Website:
https://www.contrivedatuminsights.com
Contrive Datum Insights Press Releases
Latest Contrive Datum Insights Latest Reports
Artificial Intelligence
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.
“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html
BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.
After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html
Artificial Intelligence
Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost
SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.
“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html
-
Artificial Intelligence7 days agoIn-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Uncategorized7 days agoIntegrity Food Marketing Joins Forces with CA Ferolie to Expand East Coast Reach from Maine to Florida
-
Artificial Intelligence7 days agoCogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence7 days ago
aelf Leads the Fusion of AI and Blockchain to Shape the Future of Technology
-
Uncategorized7 days ago
DFI’s Latest Compact Industrial Computer Equipped with AI Acceleration Module
-
Uncategorized7 days ago
DFI Amplifies AI Capability for the Thriving EV Market and Beyond
-
Artificial Intelligence7 days agoXinhua Silk Road: Zoomlion Access pursues high-quality development with aerial work machinery sector innovation
-
Artificial Intelligence4 days agoSilent Eight secures AIA as its latest client
